retatrutide weight loss clinical trial results Lilly's triple agonist achieves 16.8% in phase 3 Effects of once-weekly subcutaneous retatrutide

Theres not a lot of reports of people losing weight with semaglutide saying, You know what

The bottom line At the end of the day, microdosing GLP-1s is just a buzzy way of talking about a different approach to GLP-1s namely, starting (and staying) at the right dose for you, even if its lower than what the manufacturer recommends

Retatrutides 24.2% average weight loss at 48 weeks approaches the results typically achieved through bariatric surgery, which produces 25-30% weight loss

It also helps reduce glucose production in the liver, leading to improved glycemic control throughout the day

For women, this floor should be 1,200 calories

By bridging rigorous mechanistic insights with real-world therapeutic applications, we aim to underscore how a deep understanding of GLP-1 biologyspanning metabolic, cardiovascular, inflammatory, and neurohormonal pathwayscan inform more precise, effective, and individualized treatment strategies